One Source at a Time
Click to learn more!
Pilot study of the 5-HT2AR agonist C12H17N2O4P in the treatment of tobacco addiction
Journal of Psychopharmacology, 2014
This early study showed 80% of participants had achieved smoking abstinence at a 6 month follow-up. Each participant in the study on average had: 6 previous lifetime quit attempts, 19 cigarettes per day for 31 years intake. Read the abstract for yourself.
Long-term follow-up of C12H17N2O4P facilitated smoking cessation
The American Journal of Drug and Alcohol Abuse, 2017
At 12-month follow-up, 10 participants (67%) were biologically confirmed as smoking abstinent, with 8 of these participants reporting continuous abstinence since their Target-Quit-Date